Cipla gets USFDA nod for contraceptive injection

Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news